Background: Portal vein complications (PVCs) after pediatric liver transplantation (LT) are sometimes asymptomatic, especially in the early phase, and can threaten both the graft and patient's survival. Therefore, the purpose of this study is to analyze the risk factors for portal vein thrombosis (PVT) and portal vein stenosis (PVS) after pediatric LT.Methods: All pediatric patients (n = 115) who underwent primary LT at Regensburg University Hospital between January 2010 and April 2017 were included in this study.The pre-, intra-, and postoperative parameters of all patients were retrospectively reviewed and risk factors for both PVT and PVS were analyzed.Results: Of the 115 patients, living donor LT was performed on 57 (49.5%) patients, and biliary atresia was the primary diagnosis in 65 patients (56%). After pediatric LT, 9% of patients developed PVT, and 16.5% developed PVS. Patient weight ≤7 kg [odds ratio (OR) 9.35, 95% confidence interval (CI) 1.03-84.9, p = .04] and GRWR >3% (OR 15.4, 95% CI 1.98-129.5, p = .01) were the independent risk factors for the development of PVT and PVS, respectively upon multivariate analysis. The overall patient survival rates at 1, 3, and 5 years were 91%, 90%, and 89%, respectively, and there was no difference in patient survival among those with and without PVCs.Conclusions: Pediatric patients with body weight <7 kg and/or receiving a graft with GRWR >3% may develop PVCs and so require certain surgical modifications, close follow-up, and prophylactic anticoagulant therapy following transplant.
K E Y W O R D Sliver transplant, pediatric, portal vein stenosis, portal vein thrombosis, risk factors Liver transplantation (LT) remains the treatment of choice for pediatric patients with end-stage liver diseases, acute liver failure, and certain metabolic diseases. Despite the recent advances in pediatric LT techniques, still, portal vein complications (PVCs) are serious issues that threaten graft and patient survival. 1 PVCs include portal vein thrombosis (PVT) or portal vein stenosis (PVS) and have an incidence of 3%-14% after pediatric LT which is significantly higher than their incidence in adults LT. 2,3 The clinical manifestations of PVC range from completely asymptomatic to manifestations of portal hypertension such as ascites, gastrointestinal bleeding, splenomegaly, or cytopenia up to graft failure especially in the case of early PVT. 1,4 Therefore, knowing the perioperative risk factors for PVC is crucial to improve patient and graft survival posttransplant by administration of prophylaxis anticoagulant therapy and meticulous follow-up of high-risk patients.Most of the previous studies reported the risk factors for PVT in pediatric LT and included small hypoplastic portal vein (PV), use of vascular grafts, preoperative PVT, and low body weight. 5,6 Nevertheless, few studies investigated the risk factors for PVS after pediatric LT. 7 Accordingly, this study aims to investigate the risk factors for the development of PVT and PVS after pediatric LT at our center and assess th...